{"cik":1610820,"taxonomy":"ifrs-full","tag":"NoncurrentLiabilities","label":null,"description":null,"entityName":"BRIACELL THERAPEUTICS CORP.","units":{"CAD":[{"end":"2020-07-31","val":191572,"accn":"0001493152-21-028949","fy":2021,"fp":"FY","form":"40-F/A","filed":"2021-11-16","frame":"CY2020Q2I"}],"USD":[{"end":"2020-07-31","val":155940,"accn":"0001493152-21-028949","fy":2021,"fp":"FY","form":"40-F/A","filed":"2021-11-16","frame":"CY2020Q2I"},{"end":"2021-07-31","val":225444,"accn":"0001493152-21-028949","fy":2021,"fp":"FY","form":"40-F/A","filed":"2021-11-16"},{"end":"2021-07-31","val":225444,"accn":"0001493152-22-006886","fy":2022,"fp":"Q2","form":"6-K","filed":"2022-03-15"},{"end":"2021-07-31","val":225444,"accn":"0001493152-22-016599","fy":2022,"fp":"Q3","form":"6-K","filed":"2022-06-13","frame":"CY2021Q2I"},{"end":"2022-01-31","val":248486,"accn":"0001493152-22-006886","fy":2022,"fp":"Q2","form":"6-K","filed":"2022-03-15","frame":"CY2021Q4I"},{"end":"2022-04-30","val":278396,"accn":"0001493152-22-016599","fy":2022,"fp":"Q3","form":"6-K","filed":"2022-06-13","frame":"CY2022Q1I"}]}}